Insulin resistance is independently associated with peripheral and autonomic neuropathy in Korean type 2 diabetic patients

Acta Diabetologica

Volumn 49, Issue 2, 2012, Pages 97-103

  Lee, Kee Ook ^a,b   Nam, Ji Sun ^a   Ahn, Chul Woo ^a   Hong, Ji Man ^a   Kim, Seung Min ^a   Sunwoo, Il Nam ^a   Moon, Joon Shik ^c   Na, Sang Jun ^b   Choi, Young Chul ^a  

^a Yonsei University College of Medicine   (South Korea)

^b Konyang University   (South Korea)

^c UNIVERSITY OF OKLAHOMA COLLEGE OF MEDICINE   (United States)

Author keywords

Autonomic neuropathy; Insulin resistance; Peripheral neuropathy; Type 2 diabetes mellitus

Indexed keywords

HEMOGLOBIN A1C; HIGH DENSITY LIPOPROTEIN CHOLESTEROL;

ADULT; AGED; ARTICLE; AUTONOMIC NEUROPATHY; CLINICAL ASSESSMENT; CLINICAL EVALUATION; DIABETIC NEUROPATHY; DISEASE ASSOCIATION; DISEASE DURATION; FEMALE; GLYCEMIC INDEX; HUMAN; HYPERGLYCEMIA; INSULIN RESISTANCE; INSULIN TOLERANCE TEST; MAJOR CLINICAL STUDY; MALE; NERVE CONDUCTION; NON INSULIN DEPENDENT DIABETES MELLITUS; PERIPHERAL NEUROPATHY; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; RISK ASSESSMENT; RISK FACTOR;

ADULT; AGED; AUTONOMIC NERVOUS SYSTEM DISEASES; DIABETES MELLITUS, TYPE 2; DIABETIC NEUROPATHIES; FEMALE; HUMANS; INSULIN RESISTANCE; MALE; MIDDLE AGED; REPUBLIC OF KOREA; YOUNG ADULT;

EID: 84862885199     PISSN: 09405429     EISSN: 14325233     Source Type: Journal    
DOI: 10.1007/s00592-010-0176-6     Document Type: Article

References (37)

1. Jenkins AJ, Rowley KG, Lyons TJ, Best JD, Hill MA, Klein RL (2004) Lipoproteins and diabetic microvascular complications. Curr Pharm Des 10:3395-3418 (Pubitemid 39276625)
2. DeFronzo RA, Bonadonna RC, Ferrannini E (1992) Pathogenesis of NIDDM. A balanced overview. Diabetes Care 15:318-368
3. Yagihashi S, Yamagishi S, Wada R (2007) Pathology and pathogenetic mechanisms of diabetic neuropathy: correlation with clinical signs and symptoms. Diabetes Res Clin Pract 77:S184-S189 (Pubitemid 47212574)
4. Turner RC (1998) The U.K. prospective diabetes study. A review. Diabetes Care 21:C35-C38
5. Diamantopoulos EJ, Andreadis EA, Tsourous GI, Katsanou PM, Georgiopoulos DX, Nestora KC, Raptis SA (2006) Early vascular lesions in subjects with metabolic syndrome and prediabetes. Int Angiol 25:179-183 (Pubitemid 44054861)
6. Smith AG, Singleton JR (2008) Impaired glucose tolerance and neuropathy. Neurologist 14:23-29
7. Singleton JR, Smith AG, Russell JW, Feldman EL (2003) Microvascular complications of impaired glucose tolerance. Diabetes 52:2867-2873 (Pubitemid 37466854)
8. Ziegler D, Meisinger C, Rathmann W, Mielck A, Dickhaus T (2008) Prevalence of polyneuropathy in prediabetes and diabetes is associated with abdominal obesity and macroangiopathy. Diabetes Care 31:464-469
9. Gottsater A, Ahmed M, Femlund P, Sundkvist G (2001) Autonomic neuropathy in type 2 diabetic patients is associated with hyperinsulinemia and hypertriglyceridemia. Diabet Med 16:49-54
10. Nakano S, Kitazawa M, Ito T, Hatakeyama H, Nishizawa M, Nakagawa A, Kigoshi T, Uchida K (2003) Insulin resistant state in type 2 diabetes is related to advanced autonomic neuropathy. Clin Exp Hypertens 25:155-167 (Pubitemid 36438129)
11. De Jager J, Kooy A, Lehert P, Bets D, Wulffele MG, Teerlink T, Scheffer PG, Schalkwijk CG, Donker AJ, Stehouwer CD (2005) Effects of short-term treatment with metformin on markers of endothelial function and inflammatory activity in type 2 diabetes mellitus: a randomized, placebo-controlled trial. J Intern Med 257:100-109 (Pubitemid 40129131)
12. Guan Y (2004) Peroxisome proliferator-activated receptor family and its relationship to renal complications of the metabolic syndrome. J Am Soc Nephrol 15:2801-2815
13. Tesfaye S, Chaturvedi N, Eaton SE, Ward JD, Manes C, Ionescu-Tirgoviste C, Witte DR, Fuller JH, EURODIAB Prospective Complications Study Group (2005) Vascular risk factors and diabetic neuropathy. N Engl J Med 352:341-350
14. Expert Committee on the Diagnosis, Classification of Diabetes Mellitus (2003) Report of the expert committee on the diagnosis and classification of diabetes mellitus. Diabetes Care 26:S5-S20
15. Feldman EL, Stevens MJ, Thomas PK, Brown MB, Canal N, Greene DA (1994) A practical two-step quantitative clinical and electrophysiological assessment for the diagnosis and staging of diabetic neuropathy. Diabetes Care 17:1281-1289 (Pubitemid 24324972)
16. England JD, Gronseth GS, Franklin G, Miller RG, Asbury AK, Carter GT, Cohen JA, Fisher MA, Howard JF, Kinsella LJ, Latov N, Lewis RA, Low PA, Sumner AJ (2005) Distal symmetric polyneuropathy: a definition for clinical research: report of the American Academy of Neurology, the American Association of Electrodiagnostic Medicine, and the American Academy of Physical Medicine and Rehabilitation. Neurology 64:199-207
17. Hilz MJ (2002) Quantitative autonomic functional testing in clinical trials. In: Brown WF, Bolton CF, Aminoff MJ (eds) Neuromuscular function and disease. Basic, clinical and electrodiagnostic aspects. WB Saunders, Philadelphia, pp 1899-1929
18. Genovely H, Pfeifer MA (1988) RR-variation: the autonomic test of choice in diabetes. Diabetes Metab Rev 4:255-271
19. Mackay JD, Page MM, Cambridge J, Watkins PJ (1980) Diabetic autonomic neuropathy. The diagnostic value of heart rate monitoring. Diabetologia 18:471-478 (Pubitemid 10114471)
20. Ewing DJ, Campbell IW, Murray A, Neilson JM, Clarke BF (1978) Immediate heart-rate response to standing: simple test for autonomic neuropathy in diabetes. Br Med J 1:145-147 (Pubitemid 8320452)
21. Ziegler D, Dannehl K, Mühlen H, Spüler M, Gries FA (1992) Prevalence of cardiovascular autonomic dysfunction assessed by spectral analysis, vector analysis, and standard tests of heart rate variation and blood pressure responses at various stages of diabetic neuropathy. Diabet Med 9:806-814
22. Benarroch EE (1997) Central autonomic network: functional organization and clinical correlations. Armonk, Futura
23. Mosqueda-Garcia R (1995) Evaluation of autonomic failure. In: Robertson D, Biaggioni I (eds) Disorder of the autonomic nervous system. Harwood Academic Publishers, Luxembourg, pp 25-60
24. Bonora E, Moghetti P, Zancanaro C, Cigolini M, Querena M, Cacciatori V, Corgnati A, Muggeo M (1989) Estimates of in vivo insulin action in man: comparison of insulin tolerance tests with euglycemic and hyperglycemic glucose clamp studies. J Clin Endocrinol Metab 68:374-378 (Pubitemid 19052880)
25. Gelding SV, Robinson S, Lowe S, Niththyananthan R, Johnston DG (1994) Validation of the low dose short insulin tolerance test for evaluation of insulin sensitivity. Clin Endocrinol 40:611-615 (Pubitemid 24194664)
26. Dyck PJ, Davies JL, Clark VM, Litchy WJ, Dyck PJ, Klein CJ, Rizza RA, Pach JM, Klein R, Larson TS, Melton LJ 3rd, O'Brien PC (2006) Modeling chronic glycemic exposure variables as correlates and predictors of microvascular complications of diabetes. Diabetes Care 29:2282-2288 (Pubitemid 44899866)
27. Vinik AI, Erbas T, Stansberry KB, Pittenger GL (2001) Small fiber neuropathy and neurovascular disturbances in diabetes mellitus. Exp Clin Endocrinol Diabetes 109:S451-S473 (Pubitemid 32577595)
28. Thrainsdottir S, Malik RA, Dahlin LB, Wiksell P, Eriksson KF, Rosén I, Petersson J, Greene DA, Sundkvist G (2003) Endoneurial capillary abnormalities presage deterioration of glucose tolerance and accompany peripheral neuropathy in man. Diabetes 52:2615-2622 (Pubitemid 37210552)
29. Groop PH, Forsblom C, Thomas MC (2005) Mechanisms of disease: pathway-selective insulin resistance and microvascular complications of diabetes. Nature Clin Pract Endocrinol Metab 1:100-108
30. Lee RH (1999) Insulin resistance: does it play a role in peripheral neuropathy. Diabetes Care 22:1914-1915
31. Giannini C, Dyck PJ (1995) Basement membrane reduplication and pericyte degeneration precede development of diabetic polyneuropathy and are associated with its severity. Ann Neurol 37:454-459
32. Kilpatrick ES, Rigby AS, Atkin SL (2007) Insulin resistance, the metabolic syndrome, and complication risk in type 1 diabetes. Diabetes Care 30:707-712
33. Choi SH, Hur KY, Kim DJ, Ahn CW, Kang ES, Cha BS, Lim SK, Huh KB, Lee HC (2008) Staged diabetes management according to individual patient insulin resistance and β-cell function ameliorates glycaemic control in type 2 diabetes mellitus. Clin Endocrinol 69:549-555
34. Tentolouris N, Grapsas E, Stambulis E, Papageorgiou K, Katsilambros N (1999) Impact of body mass on autonomic function in persons with type 2 diabetes. Diabetes Res Clin Pract 46:29-33 (Pubitemid 29474999)
35. Maser RE, Steenkiste AR, Dorman JS, Nielsen VK, Bass EN, Manjoo Q, Drash A, Becker DJ, Kuller LH, Greene A, Orchard J (1989) Epidemiological correlates of diabetic neuropathy. Report from Pittsburg epidemiology of diabetes complications study. Diabetes 38:1456-1461 (Pubitemid 19271729)
36. Aaberg ML, Burch DM, Hud ZR, Zacharias MP (2005) Gender differences in the onset of diabetic neuropathy. J Diabetes Complicat 22:83-87
37. Booya F, Bandarian F, Larijani B, Pajouhi M, Nooraei M, Lotfi J (2005) Potential risk factors for diabetic neuropathy: a case control study. BMC Neurol 5:24-28